Stock ZVSA ZYVERSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ZyVersa Therapeutics, Inc.

Equities

ZVSA

US98987D3008

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-07 EDT 		5-day change 1st Jan Change
4.41 USD -7.16% Intraday chart for ZyVersa Therapeutics, Inc. -10.73% -51.00%
05-15 ZyVersa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-25 ZyVersa Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on ZyVersa Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f97523411098dc6d82d6.E7U9nSX11RVyDErPNzZLQMesvlZwmKXb-n8GYqTnEb4.Z9Nb-Gmj5W8hZHiJWlVydaTH3W42_-mNlR5fLs-4e-1SmFz_YJG-JR5DIQ~b55aeacfffbd76809ddd9512ba992ce9

Analyst Recommendations on ZyVersa Therapeutics, Inc.

HC Wainwright Cuts Price Target on ZyVersa Therapeutics to $12 From $24, Maintains Buy Rating MT
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike MT
HC Wainwright Starts ZyVersa Therapeutics With Buy Rating, Price Target is $2.50 MT
ZyVersa Therapeutics, Inc. Announces Article Published in Metabolism Pointing to Glomerular Cholesterol Accumulation as Key Factor Exacerbating Renal Injury and Dysfunction in Diabetic Kidney Disease CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.41 USD
Average target price
70 USD
Spread / Average Target
+1,487.30%
High Price Target
120 USD
Spread / Highest target
+2,621.09%
Low Price Target
20 USD
Spread / Lowest Target
+353.51%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ZyVersa Therapeutics, Inc.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ZVSA Stock
  4. Consensus ZyVersa Therapeutics, Inc.